Vijay Kumar
Stock Analyst at Evercore ISI Group
(3.39)
# 547
Out of 5,123 analysts
287
Total ratings
52%
Success rate
2.27%
Average return
Main Sectors:
Stocks Rated by Vijay Kumar
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| USB U.S. Bancorp | Maintains: In-Line | $60 → $65 | $60.18 | +8.02% | 8 | Feb 5, 2026 | |
| GEHC GE HealthCare Technologies | Maintains: Outperform | $95 → $98 | $83.00 | +18.07% | 6 | Feb 5, 2026 | |
| BSX Boston Scientific | Maintains: Outperform | $112 → $96 | $77.71 | +23.54% | 8 | Feb 5, 2026 | |
| AZTA Azenta | Maintains: Outperform | $50 → $45 | $28.45 | +58.17% | 10 | Feb 5, 2026 | |
| TWST Twist Bioscience | Maintains: Outperform | $42 → $52 | $47.42 | +9.66% | 7 | Feb 3, 2026 | |
| RVTY Revvity | Maintains: Outperform | $112 → $118 | $99.70 | +18.36% | 4 | Feb 3, 2026 | |
| ISRG Intuitive Surgical | Maintains: In-Line | $580 → $550 | $487.10 | +12.91% | 15 | Jan 23, 2026 | |
| ABT Abbott Laboratories | Maintains: Outperform | $144 → $138 | $109.52 | +26.00% | 18 | Jan 23, 2026 | |
| JBHT J.B. Hunt Transport Services | Maintains: Outperform | $168 → $223 | $226.99 | -1.76% | 9 | Jan 13, 2026 | |
| HOLX Hologic | Downgrades: In-Line | $79 → $78 | $74.85 | +4.21% | 17 | Jan 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: In-Line | $105 | $102.49 | +2.45% | 8 | Jan 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: In-Line | $18 | $16.77 | +7.33% | 12 | Jan 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: In-Line | $14 → $12 | $11.01 | +9.04% | 13 | Jan 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $94 → $120 | $89.12 | +34.65% | 15 | Jan 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $194 → $210 | $147.19 | +42.67% | 3 | Jan 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $155 → $160 | $129.78 | +23.29% | 8 | Jan 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $410 → $405 | $359.55 | +12.64% | 13 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $132 → $142 | $121.93 | +16.46% | 9 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $88 → $92 | $77.52 | +18.68% | 15 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $525 → $590 | $540.07 | +9.25% | 13 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $300 → $285 | $342.13 | -16.70% | 2 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $1,275 → $1,400 | $1,346.54 | +3.97% | 12 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $226 → $245 | $215.68 | +13.59% | 4 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $33 → $31 | $21.72 | +42.73% | 8 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $33 → $40 | $21.79 | +83.57% | 2 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $103 → $106 | $102.60 | +3.31% | 5 | Jul 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $48 → $46 | $22.18 | +107.39% | 4 | Jul 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: In-Line | $3 | $2.76 | +8.70% | 6 | May 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $18 → $30 | $10.02 | +199.40% | 11 | Dec 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: In-Line | $335 → $355 | $373.70 | -5.00% | 8 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $120 → $160 | $92.64 | +72.71% | 7 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $286 → $290 | $206.95 | +40.13% | 6 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $7 | $1.10 | +536.36% | 1 | May 31, 2022 |
U.S. Bancorp
Feb 5, 2026
Maintains: In-Line
Price Target: $60 → $65
Current: $60.18
Upside: +8.02%
GE HealthCare Technologies
Feb 5, 2026
Maintains: Outperform
Price Target: $95 → $98
Current: $83.00
Upside: +18.07%
Boston Scientific
Feb 5, 2026
Maintains: Outperform
Price Target: $112 → $96
Current: $77.71
Upside: +23.54%
Azenta
Feb 5, 2026
Maintains: Outperform
Price Target: $50 → $45
Current: $28.45
Upside: +58.17%
Twist Bioscience
Feb 3, 2026
Maintains: Outperform
Price Target: $42 → $52
Current: $47.42
Upside: +9.66%
Revvity
Feb 3, 2026
Maintains: Outperform
Price Target: $112 → $118
Current: $99.70
Upside: +18.36%
Intuitive Surgical
Jan 23, 2026
Maintains: In-Line
Price Target: $580 → $550
Current: $487.10
Upside: +12.91%
Abbott Laboratories
Jan 23, 2026
Maintains: Outperform
Price Target: $144 → $138
Current: $109.52
Upside: +26.00%
J.B. Hunt Transport Services
Jan 13, 2026
Maintains: Outperform
Price Target: $168 → $223
Current: $226.99
Upside: -1.76%
Hologic
Jan 5, 2026
Downgrades: In-Line
Price Target: $79 → $78
Current: $74.85
Upside: +4.21%
Jan 5, 2026
Downgrades: In-Line
Price Target: $105
Current: $102.49
Upside: +2.45%
Jan 5, 2026
Downgrades: In-Line
Price Target: $18
Current: $16.77
Upside: +7.33%
Jan 5, 2026
Downgrades: In-Line
Price Target: $14 → $12
Current: $11.01
Upside: +9.04%
Jan 5, 2026
Upgrades: Outperform
Price Target: $94 → $120
Current: $89.12
Upside: +34.65%
Jan 5, 2026
Upgrades: Outperform
Price Target: $194 → $210
Current: $147.19
Upside: +42.67%
Jan 5, 2026
Upgrades: Outperform
Price Target: $155 → $160
Current: $129.78
Upside: +23.29%
Oct 31, 2025
Maintains: Outperform
Price Target: $410 → $405
Current: $359.55
Upside: +12.64%
Oct 31, 2025
Maintains: Outperform
Price Target: $132 → $142
Current: $121.93
Upside: +16.46%
Oct 31, 2025
Maintains: Outperform
Price Target: $88 → $92
Current: $77.52
Upside: +18.68%
Oct 7, 2025
Maintains: Outperform
Price Target: $525 → $590
Current: $540.07
Upside: +9.25%
Oct 7, 2025
Maintains: Outperform
Price Target: $300 → $285
Current: $342.13
Upside: -16.70%
Oct 7, 2025
Maintains: Outperform
Price Target: $1,275 → $1,400
Current: $1,346.54
Upside: +3.97%
Oct 7, 2025
Maintains: Outperform
Price Target: $226 → $245
Current: $215.68
Upside: +13.59%
Oct 7, 2025
Maintains: Outperform
Price Target: $33 → $31
Current: $21.72
Upside: +42.73%
Aug 13, 2025
Maintains: Outperform
Price Target: $33 → $40
Current: $21.79
Upside: +83.57%
Jul 8, 2025
Maintains: Outperform
Price Target: $103 → $106
Current: $102.60
Upside: +3.31%
Jul 8, 2025
Maintains: Outperform
Price Target: $48 → $46
Current: $22.18
Upside: +107.39%
May 19, 2025
Maintains: In-Line
Price Target: $3
Current: $2.76
Upside: +8.70%
Dec 2, 2024
Upgrades: Outperform
Price Target: $18 → $30
Current: $10.02
Upside: +199.40%
Oct 1, 2024
Maintains: In-Line
Price Target: $335 → $355
Current: $373.70
Upside: -5.00%
Oct 1, 2024
Maintains: Outperform
Price Target: $120 → $160
Current: $92.64
Upside: +72.71%
Oct 1, 2024
Maintains: Outperform
Price Target: $286 → $290
Current: $206.95
Upside: +40.13%
May 31, 2022
Initiates: Outperform
Price Target: $7
Current: $1.10
Upside: +536.36%